Quanex Building Products (NX) Financials

$15.95 -0.14 (-0.88%)

Closing price 04/23/2025 03:59 PM Eastern

Extended Trading

$15.98 +0.03 (+0.17%)

As of 04/23/2025 04:28 PM Eastern

Annual Income Statements for Quanex Building Products

This table shows Quanex Building Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	29	16	-1.86	19	27	-47	38	57	88	83	33
Consolidated Net Income / (Loss)	29	16	-1.86	19	27	-47	38	57	88	83	33
Net Income / (Loss) Continuing Operations	8.34	16	-1.86	19	27	-47	38	57	110	97	42
Total Pre-Tax Income	14	23	-5.62	26	26	-36	50	80	110	97	42
Total Operating Income	14	25	36	34	36	-26	55	82	111	111	55
Total Gross Profit	131	146	218	194	193	199	193	241	268	278	306
Total Revenue	595	646	928	867	890	894	852	1,072	1,222	1,131	1,278
Operating Revenue	595	646	928	867	890	894	852	1,072	1,222	1,131	1,278
Total Cost of Revenue	465	499	711	672	697	694	659	832	953	853	972
Operating Cost of Revenue	465	499	711	672	697	694	659	832	953	853	972
Total Operating Expenses	117	122	181	160	157	226	138	159	157	167	251
Selling, General & Admin Expense	82	87	115	98	104	101	90	116	117	124	190
Depreciation Expense	34	35	53	57	52	50	47	43	40	43	60
Restructuring Charge	0.00	0.00	0.53	4.55	1.49	0.37	0.62	0.04	0.00	0.00	0.00
Total Other Income / (Expense), net	-0.47	-1.52	-42	-8.44	-9.94	-9.53	-4.97	-1.78	-1.52	-14	-13
Interest Expense	0.56	0.99	36	9.60	11	9.64	5.25	2.53	2.56	8.14	21
Other Income / (Expense), net	0.09	-0.53	-5.48	1.16	1.16	0.12	0.28	0.75	1.04	-5.52	7.85
Other Adjustments to Consolidated Net Income / (Loss)	-	-	-	-	-	-	-	-	-21	-15	-9.02
Basic Earnings per Share	$0.79	$0.47	($0.05)	$0.55	$0.77	($1.42)	$1.18	$1.72	$2.67	$2.51	$0.91
Weighted Average Basic Shares Outstanding	37.13M	33.99M	33.88M	34.23M	34.70M	32.96M	32.69M	33.19M	33.05M	32.82M	36.42M
Diluted Earnings per Share	$0.78	$0.47	($0.05)	$0.54	$0.76	($1.42)	$1.17	$1.70	$2.66	$2.50	$0.90
Weighted Average Diluted Shares Outstanding	37.68M	34.50M	33.88M	34.84M	35.03M	32.96M	32.82M	33.50M	33.21M	33.03M	36.65M
Weighted Average Basic & Diluted Shares Outstanding	58.50M	24.80M	-2.40M	34M	34.60M	33.02M	65.66M	66.50M	33.13M	33.00M	47.26M
Cash Dividends to Common per Share	$0.16	$0.16	$0.16	$0.16	$0.20	$0.32	$0.32	$0.32	$0.32	$0.32	$0.32

This table shows Quanex Building Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Income / (Loss) Attributable to Common Shareholders	26	25	1.91	22	32	27	6.25	15	25	-14	-15
Consolidated Net Income / (Loss)	26	25	1.91	22	32	27	6.25	15	25	-14	-15
Net Income / (Loss) Continuing Operations	34	30	2.36	21	36	37	7.89	15	32	-13	-20
Total Pre-Tax Income	34	28	2.36	27	36	32	6.85	20	32	-18	-20
Total Operating Income	34	29	4.40	29	37	39	7.92	21	23	2.83	-6.98
Total Gross Profit	73	67	52	67	79	80	51	66	71	117	92
Total Revenue	324	308	262	274	300	295	239	266	280	492	400
Operating Revenue	324	308	262	274	300	295	239	266	280	492	400
Total Cost of Revenue	251	240	210	206	221	215	188	200	209	375	308
Operating Cost of Revenue	251	240	210	206	221	215	188	200	209	375	308
Total Operating Expenses	39	39	47	38	41	41	44	46	47	114	99
Selling, General & Admin Expense	29	29	37	27	31	29	32	35	37	87	67
Depreciation Expense	9.73	9.56	11	10	11	11	11	11	11	27	25
Restructuring Charge	-	-	-	-	-	-	0.00	-	-	-	7.90
Total Other Income / (Expense), net	-0.33	-0.52	-2.04	-2.24	-1.67	-7.70	-1.07	-0.95	8.60	-20	-13
Interest Expense	0.72	0.71	2.26	2.24	2.07	1.57	1.07	0.95	0.88	18	14
Other Income / (Expense), net	0.40	-	0.22	-	0.40	-	-	-	9.47	-	1.23
Income Tax Expense	-	-	0.45	5.55	4.10	-	1.64	4.31	6.69	-	-5.05
Basic Earnings per Share	$0.79	$0.74	$0.06	$0.65	$0.97	$0.83	$0.19	$0.47	$0.77	($0.52)	($0.32)
Weighted Average Basic Shares Outstanding	33.00M	33.05M	32.95M	32.86M	32.72M	32.82M	32.83M	32.87M	32.88M	36.42M	47.02M
Diluted Earnings per Share	$0.78	$0.74	$0.06	$0.65	$0.96	$0.83	$0.19	$0.46	$0.77	($0.52)	($0.32)
Weighted Average Diluted Shares Outstanding	33.17M	33.21M	33.14M	33.02M	32.92M	33.03M	33.04M	33.10M	33.11M	36.65M	47.02M
Weighted Average Basic & Diluted Shares Outstanding	66.26M	33.13M	33.24M	32.95M	32.99M	33.00M	33.10M	33.11M	47.25M	47.26M	47.23M
Cash Dividends to Common per Share	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08

This table details how cash moves in and out of Quanex Building Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	71	-97	2.40	-8.07	12	1.87	21	-12	15	3.38	45
Net Cash From Operating Activities	21	67	87	80	105	96	101	79	98	147	89
Net Cash From Continuing Operating Activities	21	67	87	80	105	96	101	79	98	147	89
Net Income / (Loss) Continuing Operations	29	16	-1.86	19	27	-47	38	57	88	83	33
Consolidated Net Income / (Loss)	29	16	-1.86	19	27	-47	38	57	88	83	33
Depreciation Expense	37	35	53	57	52	50	47	43	40	43	60
Non-Cash Adjustments To Reconcile Net Income	-37	3.44	19	6.72	1.73	77	0.88	5.01	2.40	2.80	-5.31
Changes in Operating Assets and Liabilities, net	-8.70	12	1.36	-3.01	23	16	14	-26	-33	19	0.73
Net Cash From Investing Activities	74	-160	-282	-33	-26	-24	-25	-19	-33	-128	-421
Net Cash From Continuing Investing Activities	74	-160	-282	-33	-26	-24	-25	-19	-33	-128	-421
Purchase of Property, Plant & Equipment	-34	-30	-37	-35	-26	-25	-26	-24	-33	-37	-37
Acquisitions	-5.16	-132	-246	-	-	-	-	0.00	0.00	-91	-399
Sale of Property, Plant & Equipment	0.83	0.26	1.04	1.94	0.43	1.32	0.50	5.30	0.16	0.25	15
Net Cash From Financing Activities	-24	-4.58	195	-55	-66	-71	-55	-72	-46	-16	385
Net Cash From Continuing Financing Activities	-24	-4.58	195	-55	-66	-71	-55	-72	-46	-16	385
Repayment of Debt	-0.18	-69	-436	-102	-299	-138	-155	-66	-98	-103	-394
Repurchase of Common Equity	-22	-53	0.00	0.00	-32	-9.55	-7.23	-11	-6.60	-5.59	0.00
Payment of Dividends	-5.99	-5.52	-5.47	-5.52	-7.02	-11	-11	-11	-11	-11	-12
Issuance of Debt	0.09	117	635	54	269	84	115	0.00	71	102	785
Other Financing Activities, net	3.90	5.17	2.61	-1.52	3.79	2.96	3.17	16	-0.72	0.65	5.89
Effect of Exchange Rate Changes	0.21	0.38	1.72	-0.09	-1.19	0.32	0.30	0.42	-4.09	0.92	-8.85

This table details how cash moves in and out of Quanex Building Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Change in Cash & Equivalents	11	5.06	-12	0.44	30	-15	-14	12	38	9.03	-48
Net Cash From Operating Activities	52	48	3.14	35	64	44	3.85	33	46	5.48	-13
Net Cash From Continuing Operating Activities	52	48	3.14	35	64	44	3.85	33	46	5.48	-13
Net Income / (Loss) Continuing Operations	26	25	1.91	22	32	27	6.25	15	25	-14	-15
Consolidated Net Income / (Loss)	26	25	1.91	22	32	27	6.25	15	25	-14	-15
Depreciation Expense	9.73	9.56	11	10	11	11	11	11	11	27	25
Non-Cash Adjustments To Reconcile Net Income	1.70	-1.95	2.19	0.19	1.87	-1.45	3.51	-0.85	-7.68	0.85	7.08
Changes in Operating Assets and Liabilities, net	14	16	-12	3.17	20	7.37	-17	7.67	18	-8.78	-29
Net Cash From Investing Activities	-5.61	-14	-99	-6.79	-7.29	-15	-9.55	-7.54	-6.23	-397	-11
Net Cash From Continuing Investing Activities	-5.61	-14	-99	-6.79	-7.29	-15	-9.55	-7.54	-6.23	-397	-11
Purchase of Property, Plant & Equipment	-5.70	-14	-7.58	-7.49	-7.38	-15	-9.58	-7.60	-6.25	-14	-12
Acquisitions	-	-	-92	0.70	-	-	0.00	-	-	-399	0.00
Sale of Property, Plant & Equipment	0.10	0.03	0.10	0.00	0.08	0.07	0.03	0.06	0.02	15	0.17
Net Cash From Financing Activities	-34	-28	83	-29	-28	-43	-9.12	-13	-3.57	411	-22
Net Cash From Continuing Financing Activities	-34	-28	83	-29	-28	-43	-9.12	-13	-3.57	411	-22
Repayment of Debt	-27	-25	-16	-21	-26	-41	-5.68	-10	-0.94	-377	-58
Repurchase of Common Equity	-5.03	-	0.00	-5.59	-	-	0.00	-	-	-	-3.70
Payment of Dividends	-2.66	-2.68	-2.66	-2.66	-2.63	-2.69	-2.65	-2.65	-2.65	-4.03	-3.81
Issuance of Debt	-	-	102	-	-	-	0.00	-	-	785	45
Other Financing Activities, net	0.33	0.19	-0.45	-0.02	0.65	0.46	-0.79	0.15	0.02	6.51	-1.19
Effect of Exchange Rate Changes	-0.56	-1.50	1.00	0.91	-	-	0.76	-1.05	1.23	-9.79	-1.59

This table presents Quanex Building Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	517	566	780	774	743	645	692	717	725	831	2,320
Total Current Assets	260	158	204	192	191	190	207	249	281	274	611
Cash & Equivalents	120	23	26	17	29	31	52	40	55	58	98
Restricted Cash	-	-	-	-	-	-	-	-	-	0.00	5.25
Accounts Receivable	55	64	84	79	84	83	88	108	96	97	198
Inventories, net	57	63	84	88	71	67	61	93	121	98	276
Prepaid Expenses	6.05	7.99	10	7.41	7.30	9.35	6.22	8.15	8.66	12	29
Current Deferred & Refundable Income Taxes	21	-	-	-	-	-	-	-	0.00	8.30	5.94
Plant, Property, & Equipment, net	109	141	198	211	201	194	184	179	180	251	402
Total Noncurrent Assets	147	267	378	371	351	261	300	290	264	307	1,306
Goodwill	71	130	217	222	220	146	146	149	138	183	575
Intangible Assets	70	121	154	140	122	107	93	82	65	74	598
Noncurrent Deferred & Refundable Income Taxes	1.55	8.78	-	-	-	-	-	-	-	0.00	3.85
Other Noncurrent Operating Assets	4.96	7.26	6.67	8.98	9.26	8.32	61	58	61	50	130
Total Liabilities & Shareholders' Equity	517	566	780	774	743	645	692	717	725	831	2,320
Total Liabilities	96	170	413	367	348	315	336	298	260	286	1,309
Total Current Liabilities	74	88	114	106	102	110	130	158	140	135	273
Short-Term Debt	0.20	2.36	11	21	1.22	0.75	0.69	0.85	1.05	2.37	26
Accounts Payable	41	48	48	44	52	64	77	87	78	74	124
Accrued Expenses	32	37	55	39	46	39	38	56	52	50	104
Current Deferred & Payable Income Tax Liabilities	0.11	0.75	0.73	2.19	2.78	6.18	6.47	6.04	1.05	0.38	6.62
Other Current Liabilities	-	-	-	-	-	0.00	7.46	8.20	7.73	7.22	12
Total Noncurrent Liabilities	22	82	298	261	246	205	206	140	120	151	1,036
Long-Term Debt	0.59	54	259	218	209	156	117	52	30	66	737
Noncurrent Deferred & Payable Income Tax Liabilities	4.63	0.56	19	23	18	20	20	23	24	29	162
Other Noncurrent Operating Liabilities	12	22	12	15	14	16	58	59	63	55	137
Commitments & Contingencies	-	-	-	-	-	-	-	-	-	-	0.00
Total Equity & Noncontrolling Interests	421	395	368	407	395	330	356	420	465	546	1,011
Total Preferred & Common Equity	421	395	368	407	395	330	356	420	465	546	1,011
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	421	395	368	407	395	330	356	420	465	546	1,011
Common Stock	250	251	255	256	255	255	254	255	252	252	702
Retained Earnings	202	222	214	226	244	186	214	260	337	409	430
Treasury Stock	-26	-68	-62	-50	-73	-77	-79	-73	-76	-78	-75
Accumulated Other Comprehensive Income / (Loss)	-5.71	-10	-39	-25	-31	-34	-33	-22	-49	-38	-46

This table presents Quanex Building Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Total Assets	744	827	822	848	813	837	872	2,220
Total Current Assets	306	267	264	288	253	264	301	548
Cash & Equivalents	50	43	43	73	44	56	94	50
Restricted Cash	-	-	-	-	-	-	-	5.49
Accounts Receivable	109	85	94	96	80	87	88	164
Inventories, net	138	128	114	105	107	101	99	281
Prepaid Expenses	8.65	11	12	13	13	13	19	42
Current Deferred & Refundable Income Taxes	-	-	-	-	7.64	6.05	1.45	5.28
Plant, Property, & Equipment, net	175	242	243	246	254	253	252	391
Total Noncurrent Assets	262	318	316	314	307	321	319	1,282
Goodwill	141	185	185	186	185	184	186	570
Intangible Assets	70	83	81	79	72	69	67	580
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	3.71
Other Noncurrent Operating Assets	51	50	50	49	49	68	66	128
Total Liabilities & Shareholders' Equity	744	827	822	848	813	837	872	2,220
Total Liabilities	293	351	329	322	258	271	278	1,248
Total Current Liabilities	159	120	119	135	111	119	128	229
Short-Term Debt	1.07	2.00	2.11	2.28	2.50	2.63	2.69	26
Accounts Payable	85	63	64	71	55	61	64	108
Accrued Expenses	51	46	45	54	46	49	55	81
Current Deferred & Payable Income Tax Liabilities	14	1.62	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	7.97	7.21	7.40	7.39	7.37	6.43	6.44	13
Total Noncurrent Liabilities	135	231	211	186	147	153	150	1,020
Long-Term Debt	55	152	132	107	62	52	51	725
Noncurrent Deferred & Payable Income Tax Liabilities	21	23	23	24	31	29	27	163
Other Noncurrent Operating Liabilities	54	56	55	56	55	72	72	132
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	450	476	493	526	555	566	594	972
Total Preferred & Common Equity	450	476	493	526	555	566	594	972
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	450	476	493	526	555	566	594	972
Common Stock	252	250	251	251	249	250	251	698
Retained Earnings	315	337	356	385	413	426	448	412
Treasury Stock	-76	-73	-79	-78	-75	-75	-75	-75
Accumulated Other Comprehensive Income / (Loss)	-41	-38	-35	-32	-32	-35	-30	-62

This table displays calculated financial ratios and metrics derived from Quanex Building Products' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.30%	8.42%	43.79%	-6.64%	2.68%	0.46%	-4.73%	25.90%	13.93%	-7.44%	13.03%
EBITDA Growth	22.52%	15.77%	68.52%	-7.45%	-3.08%	-74.06%	341.56%	21.97%	21.60%	-2.88%	-16.92%
EBIT Growth	177.04%	68.04%	27.87%	13.68%	5.00%	-171.39%	311.11%	48.75%	35.94%	-6.36%	-40.41%
NOPAT Growth	165.44%	93.00%	52.92%	-2.30%	48.04%	-150.26%	328.64%	37.70%	91.06%	-0.52%	-50.47%
Net Income Growth	349.80%	-44.95%	-111.55%	1,105.00%	42.12%	-275.99%	182.38%	48.02%	55.03%	-6.61%	-59.93%
EPS Growth	343.75%	-39.74%	-110.64%	1,180.00%	40.74%	-286.84%	182.39%	45.30%	56.47%	-6.02%	-64.00%
Operating Cash Flow Growth	-52.26%	222.88%	30.19%	-8.66%	31.13%	-7.88%	4.59%	-22.03%	24.66%	50.11%	-39.61%
Free Cash Flow Firm Growth	-90.26%	-2,795.79%	-43.29%	104.98%	1,027.44%	14.57%	-24.15%	-38.95%	119.61%	-104.60%	-22,154.63%
Invested Capital Growth	1.53%	42.14%	42.85%	2.78%	-8.28%	-20.86%	-7.65%	2.63%	1.79%	26.22%	200.55%
Revenue Q/Q Growth	14.76%	5.15%	6.14%	-1.84%	1.27%	-0.41%	1.80%	3.51%	1.31%	-1.05%	18.19%
EBITDA Q/Q Growth	-16.14%	27.97%	-6.13%	12.43%	-3.37%	-60.35%	97.68%	-1.55%	1.25%	5.00%	-9.35%
EBIT Q/Q Growth	164.07%	78.47%	-23.30%	38.89%	-7.41%	-392.57%	1,396.36%	-0.95%	2.29%	5.42%	-31.50%
NOPAT Q/Q Growth	197.21%	85.24%	18.26%	13.50%	-7.53%	-393.86%	1,527.77%	-29.49%	1.35%	10.95%	-40.08%
Net Income Q/Q Growth	26.71%	44.90%	-170.07%	39.61%	-13.13%	-415.50%	363.60%	-2.15%	4.46%	3.40%	-55.54%
EPS Q/Q Growth	30.00%	42.42%	-171.43%	38.46%	-14.61%	-389.66%	365.91%	-2.86%	4.72%	3.73%	-60.00%
Operating Cash Flow Q/Q Growth	-57.68%	63.23%	1.48%	-5.86%	27.94%	11.81%	-11.50%	-21.94%	20.93%	-2.40%	-30.52%
Free Cash Flow Firm Q/Q Growth	-95.47%	16.50%	6.65%	-66.58%	48.22%	20.11%	-17.55%	-52.49%	17.41%	17.99%	-1,165.91%
Invested Capital Q/Q Growth	-3.10%	-5.26%	-4.84%	-1.94%	-7.14%	-15.88%	-6.66%	-0.54%	-3.55%	-1.13%	201.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.97%	22.68%	23.44%	22.40%	21.66%	22.31%	22.64%	22.44%	21.98%	24.55%	23.92%
EBITDA Margin	8.61%	9.20%	10.78%	10.69%	10.09%	2.60%	12.07%	11.69%	12.48%	13.09%	9.63%
Operating Margin	2.40%	3.82%	3.92%	3.92%	4.01%	-2.96%	6.49%	7.64%	9.11%	9.79%	4.29%
EBIT Margin	2.41%	3.74%	3.33%	4.05%	4.14%	-2.94%	6.52%	7.71%	9.20%	9.30%	4.90%
Profit (Net Income) Margin	4.91%	2.49%	-0.20%	2.16%	2.98%	-5.23%	4.52%	5.31%	7.23%	7.30%	2.59%
Tax Burden Percent	211.75%	69.51%	33.05%	73.26%	103.11%	129.97%	76.53%	71.14%	80.48%	85.01%	78.56%
Interest Burden Percent	96.09%	95.90%	-18.22%	72.66%	69.88%	136.65%	90.56%	96.94%	97.72%	92.26%	67.14%
Effective Tax Rate	39.61%	32.56%	0.00%	26.74%	-3.11%	0.00%	23.47%	28.86%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.88%	4.56%	4.89%	4.01%	6.11%	-3.58%	9.63%	13.64%	25.49%	22.22%	4.92%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.37%	5.83%	-14.82%	1.36%	1.02%	-21.92%	5.68%	10.42%	423.15%	422.42%	-1.57%
Return on Net Nonoperating Assets (RNNOA)	4.10%	-0.62%	-5.38%	0.82%	0.52%	-9.30%	1.59%	1.06%	-5.52%	-5.89%	-0.68%
Return on Equity (ROE)	6.98%	3.94%	-0.49%	4.82%	6.62%	-12.88%	11.22%	14.69%	19.97%	16.33%	4.25%
Cash Return on Invested Capital (CROIC)	1.37%	-30.24%	-30.40%	1.27%	14.74%	19.70%	17.59%	11.04%	23.72%	-0.96%	-95.21%
Operating Return on Assets (OROA)	2.64%	4.46%	4.59%	4.52%	4.86%	-3.79%	8.31%	11.73%	15.58%	13.52%	3.98%
Return on Assets (ROA)	5.37%	2.97%	-0.28%	2.40%	3.50%	-6.73%	5.76%	8.09%	12.25%	10.61%	2.10%
Return on Common Equity (ROCE)	6.98%	3.94%	-0.49%	4.82%	6.62%	-12.88%	11.22%	14.69%	19.97%	16.33%	4.25%
Return on Equity Simple (ROE_SIMPLE)	6.95%	4.07%	-0.51%	4.59%	6.72%	-14.15%	10.82%	13.57%	19.00%	15.12%	3.27%
Net Operating Profit after Tax (NOPAT)	8.62	17	25	25	37	-18	42	58	111	111	55
NOPAT Margin	1.45%	2.58%	2.74%	2.87%	4.14%	-2.07%	4.97%	5.43%	9.11%	9.79%	4.29%
Net Nonoperating Expense Percent (NNEP)	17.25%	-1.26%	19.72%	2.65%	5.08%	18.34%	3.96%	3.21%	-397.66%	-400.20%	6.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	22.46%	18.02%	3.09%
Cost of Revenue to Revenue	78.03%	77.32%	76.56%	77.60%	78.34%	77.69%	77.36%	77.56%	78.02%	75.45%	76.08%
SG&A Expenses to Revenue	13.80%	13.41%	12.38%	11.32%	11.66%	11.33%	10.53%	10.82%	9.59%	10.96%	14.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.57%	18.86%	19.52%	18.48%	17.65%	25.27%	16.15%	14.81%	12.87%	14.76%	19.63%
Earnings before Interest and Taxes (EBIT)	14	24	31	35	37	-26	56	83	112	105	63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	51	59	100	93	90	23	103	125	152	148	123
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.58	1.44	1.36	1.70	1.21	1.81	1.60	1.60	1.54	1.60	1.35
Price to Tangible Book Value (P/TBV)	2.37	3.94	0.00	15.38	8.87	7.71	4.88	3.56	2.73	3.03	0.00
Price to Revenue (P/Rev)	1.11	0.88	0.54	0.80	0.54	0.67	0.67	0.63	0.59	0.77	1.07
Price to Earnings (P/E)	22.68	35.39	0.00	36.93	17.94	0.00	14.77	11.77	8.09	10.59	41.42
Dividend Yield	0.91%	0.95%	1.09%	0.81%	1.48%	1.78%	1.85%	1.60%	1.48%	1.21%	1.10%
Earnings Yield	4.41%	2.83%	0.00%	2.71%	5.57%	0.00%	6.77%	8.50%	12.36%	9.44%	2.41%
Enterprise Value to Invested Capital (EV/IC)	1.80	1.41	1.22	1.45	1.14	1.58	1.51	1.58	1.57	1.59	1.21
Enterprise Value to Revenue (EV/Rev)	0.91	0.93	0.80	1.05	0.74	0.81	0.75	0.64	0.57	0.78	1.59
Enterprise Value to EBITDA (EV/EBITDA)	10.60	10.15	7.44	9.85	7.33	31.05	6.17	5.45	4.53	5.97	16.50
Enterprise Value to EBIT (EV/EBIT)	37.83	24.95	24.12	25.98	17.85	0.00	11.42	8.27	6.15	8.41	32.38
Enterprise Value to NOPAT (EV/NOPAT)	63.04	36.21	29.27	36.68	17.87	0.00	15.00	11.73	6.20	7.99	37.01
Enterprise Value to Operating Cash Flow (EV/OCF)	26.16	8.98	8.53	11.43	6.29	7.50	6.29	8.70	7.05	6.01	22.85
Enterprise Value to Free Cash Flow (EV/FCFF)	132.80	0.00	0.00	115.72	7.40	7.10	8.22	14.50	6.67	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.14	0.73	0.59	0.53	0.48	0.33	0.13	0.07	0.13	0.75
Long-Term Debt to Equity	0.00	0.14	0.70	0.54	0.53	0.47	0.33	0.12	0.06	0.12	0.73
Financial Leverage	-0.29	-0.11	0.36	0.60	0.50	0.42	0.28	0.10	-0.01	-0.01	0.43
Leverage Ratio	1.30	1.33	1.76	2.01	1.89	1.91	1.95	1.82	1.63	1.54	2.02
Compound Leverage Factor	1.25	1.27	-0.32	1.46	1.32	2.62	1.76	1.76	1.59	1.42	1.36
Debt to Total Capital	0.19%	12.43%	42.29%	37.05%	34.76%	32.25%	24.82%	11.20%	6.19%	11.20%	43.01%
Short-Term Debt to Total Capital	0.05%	0.52%	1.65%	3.29%	0.20%	0.15%	0.15%	0.18%	0.21%	0.39%	1.45%
Long-Term Debt to Total Capital	0.14%	11.91%	40.64%	33.76%	34.56%	32.10%	24.67%	11.02%	5.98%	10.81%	41.56%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.81%	87.57%	57.71%	62.95%	65.24%	67.75%	75.18%	88.80%	93.81%	88.80%	56.99%
Debt to EBITDA	0.02	0.95	2.69	2.59	2.35	6.75	1.14	0.42	0.20	0.46	6.20
Net Debt to EBITDA	-2.33	0.56	2.44	2.40	2.02	5.43	0.64	0.10	-0.16	0.07	5.37
Long-Term Debt to EBITDA	0.01	0.91	2.59	2.36	2.33	6.72	1.14	0.42	0.19	0.45	5.99
Debt to NOPAT	0.09	3.37	10.59	9.63	5.72	-8.50	2.78	0.91	0.28	0.62	13.92
Net Debt to NOPAT	-13.87	1.98	9.59	8.93	4.93	-6.83	1.56	0.22	-0.22	0.09	12.04
Long-Term Debt to NOPAT	0.07	3.23	10.18	8.78	5.69	-8.46	2.76	0.89	0.27	0.60	13.45
Altman Z-Score	6.36	3.99	2.57	2.94	2.78	2.94	3.08	3.89	4.73	4.50	1.70
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.51	1.79	1.79	1.80	1.87	1.73	1.59	1.58	2.01	2.03	2.24
Quick Ratio	2.36	0.99	0.96	0.91	1.10	1.04	1.07	0.94	1.08	1.16	1.08
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4.09	-110	-158	7.88	89	102	77	47	104	-4.76	-1,060
Operating Cash Flow to CapEx	63.06%	225.75%	241.28%	244.52%	401.55%	409.07%	399.60%	420.08%	297.21%	395.97%	402.96%
Free Cash Flow to Firm to Interest Expense	7.28	-111.34	-4.33	0.82	8.00	10.56	14.72	18.63	40.46	-0.59	-51.47
Operating Cash Flow to Interest Expense	36.97	67.70	2.39	8.31	9.42	9.99	19.22	31.06	38.28	18.07	4.31
Operating Cash Flow Less CapEx to Interest Expense	-21.65	37.71	1.40	4.91	7.08	7.55	14.41	23.67	25.40	13.51	3.24
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.09	1.19	1.38	1.12	1.17	1.29	1.27	1.52	1.69	1.45	0.81
Accounts Receivable Turnover	10.39	10.82	12.57	10.63	10.89	10.71	9.95	10.91	11.96	11.70	8.66
Inventory Turnover	9.38	8.29	9.64	7.83	8.81	10.07	10.27	10.82	8.93	7.80	5.21
Fixed Asset Turnover	5.51	5.16	5.47	4.23	4.31	4.53	4.51	5.91	6.80	5.25	3.91
Accounts Payable Turnover	11.76	11.18	14.87	14.63	14.44	11.97	9.35	10.13	11.57	11.20	9.78
Days Sales Outstanding (DSO)	35.14	33.72	29.04	34.34	33.52	34.09	36.70	33.46	30.53	31.21	42.13
Days Inventory Outstanding (DIO)	38.90	44.02	37.84	46.64	41.44	36.24	35.56	33.74	40.87	46.82	70.11
Days Payable Outstanding (DPO)	31.04	32.64	24.54	24.95	25.28	30.48	39.05	36.02	31.53	32.58	37.31
Cash Conversion Cycle (CCC)	43.01	45.10	42.35	56.03	49.68	39.84	33.21	31.18	39.86	45.45	74.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	301	428	612	629	577	456	422	433	440	556	1,671
Invested Capital Turnover	1.99	1.77	1.78	1.40	1.48	1.73	1.94	2.51	2.80	2.27	1.15
Increase / (Decrease) in Invested Capital	4.53	127	184	17	-52	-120	-35	11	7.76	115	1,115
Enterprise Value (EV)	544	602	745	912	658	723	634	683	690	884	2,029
Market Capitalization	663	569	501	690	476	597	569	670	715	874	1,369
Book Value per Share	$11.21	$11.65	$10.75	$11.71	$11.24	$9.96	$10.84	$12.52	$14.03	$16.54	$21.39
Tangible Book Value per Share	$7.47	$4.27	($0.10)	$1.29	$1.53	$2.33	$3.55	$5.61	$7.91	$8.75	($3.43)
Total Capital	422	451	637	646	606	487	473	473	496	614	1,774
Total Debt	0.79	56	270	239	211	157	117	53	31	69	763
Total Long-Term Debt	0.59	54	259	218	209	156	117	52	30	66	737
Net Debt	-120	33	244	222	182	126	66	13	-24	10	660
Capital Expenditures (CapEx)	33	30	36	33	26	24	25	19	33	37	22
Debt-free, Cash-free Net Working Capital (DFCFNWC)	66	49	75	89	61	50	26	52	87	83	261
Debt-free Net Working Capital (DFNWC)	186	72	100	107	90	81	78	92	142	141	364
Net Working Capital (NWC)	186	70	90	85	89	81	77	91	141	139	338
Net Nonoperating Expense (NNE)	-21	0.55	27	6.18	10	28	3.80	1.26	23	28	22
Net Nonoperating Obligations (NNO)	-120	33	244	222	182	126	66	13	-24	10	660
Total Depreciation and Amortization (D&A)	37	35	69	57	53	50	47	43	40	43	60
Debt-free, Cash-free Net Working Capital to Revenue	11.08%	7.62%	8.06%	10.29%	6.84%	5.64%	3.07%	4.83%	7.10%	7.33%	20.44%
Debt-free Net Working Capital to Revenue	31.30%	11.21%	10.81%	12.30%	10.10%	9.10%	9.13%	8.57%	11.61%	12.50%	28.50%
Net Working Capital to Revenue	31.27%	10.84%	9.68%	9.85%	9.97%	9.01%	9.05%	8.49%	11.53%	12.29%	26.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.79	$0.47	($0.05)	$0.55	$0.76	($1.42)	$1.18	$1.72	$0.00	$2.51	$0.91
Adjusted Weighted Average Basic Shares Outstanding	37.13M	33.99M	33.88M	34.23M	34.70M	32.96M	32.69M	33.19M	0.00	32.82M	36.42M
Adjusted Diluted Earnings per Share	$0.78	$0.47	($0.05)	$0.54	$0.75	($1.42)	$1.17	$1.70	$0.00	$2.50	$0.90
Adjusted Weighted Average Diluted Shares Outstanding	37.68M	34.50M	33.88M	34.84M	35.03M	32.96M	32.82M	33.50M	0.00	33.03M	36.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.14M	33.97M	34.20M	34.85M	33.50M	33.02M	65.66M	66.50M	0.00	33.00M	47.26M
Normalized Net Operating Profit after Tax (NOPAT)	8.93	17	35	28	26	34	43	58	78	77	38
Normalized NOPAT Margin	1.50%	2.58%	3.73%	3.25%	2.93%	3.80%	5.02%	5.44%	6.38%	6.85%	3.00%
Pre Tax Income Margin	2.32%	3.59%	-0.61%	2.94%	2.89%	-4.02%	5.91%	7.47%	8.99%	8.58%	3.29%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	25.57	24.36	0.85	3.66	3.32	-2.73	10.59	32.66	43.89	12.93	3.04
NOPAT to Interest Expense	15.34	16.79	0.70	2.59	3.32	-1.92	8.06	23.02	43.49	13.61	2.66
EBIT Less CapEx to Interest Expense	-33.06	-5.62	-0.15	0.26	0.97	-5.17	5.78	25.26	31.01	8.36	1.97
NOPAT Less CapEx to Interest Expense	-43.28	-13.20	-0.29	-0.81	0.97	-4.36	3.25	15.63	30.61	9.04	1.59
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	20.50%	34.27%	-294.24%	29.52%	26.44%	-22.78%	27.36%	18.92%	12.00%	12.90%	36.21%
Augmented Payout Ratio	96.71%	361.86%	-294.24%	29.52%	147.08%	-43.22%	46.15%	38.54%	19.47%	19.67%	36.21%

This table displays calculated financial ratios and metrics derived from Quanex Building Products' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.78%	5.40%	-1.92%	-15.29%	-7.53%	-3.92%	-8.69%	-2.68%	-6.44%	66.56%	67.27%
EBITDA Growth	36.18%	1.96%	-37.49%	-12.67%	9.72%	32.97%	25.12%	-20.76%	-9.48%	-40.51%	-0.41%
EBIT Growth	58.31%	5.03%	-67.29%	-16.19%	9.97%	38.25%	71.33%	-29.65%	-13.07%	-92.84%	-172.62%
NOPAT Growth	144.09%	5.45%	-69.36%	-32.51%	-2.53%	38.25%	69.14%	-30.89%	-44.09%	-94.98%	-181.15%
Net Income Growth	89.40%	18.04%	-83.01%	-18.89%	22.35%	11.01%	227.34%	-28.52%	-20.03%	-150.83%	-338.20%
EPS Growth	90.24%	19.35%	-82.35%	-18.75%	23.08%	12.16%	216.67%	-29.23%	-19.79%	-162.65%	-268.42%
Operating Cash Flow Growth	180.03%	54.43%	114.48%	78.68%	23.90%	-7.52%	22.93%	-6.32%	-27.63%	-87.69%	-424.60%
Free Cash Flow Firm Growth	-59.41%	30.18%	-868.02%	-1,478.78%	-683.74%	-464.95%	115.68%	141.05%	136.60%	-1,364.93%	-6,327.76%
Invested Capital Growth	4.97%	1.79%	24.67%	23.15%	23.12%	26.22%	-1.98%	-3.31%	-1.41%	200.55%	190.19%
Revenue Q/Q Growth	0.35%	-5.09%	-14.83%	4.44%	9.54%	-1.38%	-19.07%	11.31%	5.31%	75.56%	-18.72%
EBITDA Q/Q Growth	-3.07%	-13.68%	-60.02%	161.09%	21.79%	4.61%	-62.38%	56.78%	39.13%	-31.25%	-37.03%
EBIT Q/Q Growth	-1.63%	-17.03%	-83.83%	534.84%	29.07%	4.32%	-79.96%	130.35%	59.50%	-91.40%	-303.14%
NOPAT Q/Q Growth	-1.49%	-16.06%	-87.54%	555.29%	42.26%	19.07%	-84.76%	103.56%	15.10%	-89.32%	-346.57%
Net Income Q/Q Growth	-2.32%	-4.79%	-92.26%	1,026.87%	47.35%	-13.62%	-77.18%	146.07%	64.86%	-154.90%	-6.96%
EPS Q/Q Growth	-2.50%	-5.13%	-91.89%	983.33%	47.69%	-13.54%	-77.11%	142.11%	67.39%	-167.53%	38.46%
Operating Cash Flow Q/Q Growth	161.68%	-7.00%	-93.48%	1,026.79%	81.46%	-30.59%	-91.34%	758.61%	40.18%	-88.19%	-328.33%
Free Cash Flow Firm Q/Q Growth	326.72%	67.81%	-640.21%	23.18%	16.17%	-4.91%	123.21%	81.57%	-25.27%	-4,299.78%	1.34%
Invested Capital Q/Q Growth	-3.62%	-3.55%	33.13%	-0.48%	-3.65%	-1.13%	3.39%	-1.84%	-1.75%	201.42%	-0.18%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.40%	21.94%	19.76%	24.55%	26.22%	27.08%	21.51%	24.88%	25.29%	23.78%	23.08%
EBITDA Margin	13.63%	12.40%	5.82%	14.55%	16.17%	17.16%	7.97%	11.84%	15.65%	6.13%	4.75%
Operating Margin	10.50%	9.29%	1.68%	10.72%	12.50%	13.37%	3.31%	7.75%	8.36%	0.58%	-1.74%
EBIT Margin	10.63%	9.29%	1.76%	10.72%	12.64%	13.37%	3.31%	7.75%	11.74%	0.58%	-1.44%
Profit (Net Income) Margin	8.00%	8.02%	0.73%	7.86%	10.58%	9.27%	2.61%	5.78%	9.04%	-2.83%	-3.72%
Tax Burden Percent	76.86%	87.94%	80.82%	79.49%	88.55%	86.04%	91.24%	78.09%	79.12%	79.35%	74.67%
Interest Burden Percent	97.90%	98.18%	51.11%	92.25%	94.54%	80.57%	86.51%	95.42%	97.33%	-619.72%	346.76%
Effective Tax Rate	0.00%	0.00%	19.18%	20.51%	11.45%	0.00%	23.97%	21.91%	20.88%	0.00%	0.00%
Return on Invested Capital (ROIC)	28.41%	26.00%	3.13%	18.82%	24.83%	30.34%	4.80%	11.61%	12.81%	0.46%	-1.57%
ROIC Less NNEP Spread (ROIC-NNEP)	-16.60%	93.64%	1.02%	16.00%	17.93%	202.30%	5.16%	9.95%	-364.00%	-4.28%	-4.36%
Return on Net Nonoperating Assets (RNNOA)	-0.70%	-1.22%	0.18%	2.21%	0.79%	-2.82%	0.65%	0.83%	1.17%	-1.84%	-2.04%
Return on Equity (ROE)	27.71%	24.77%	3.31%	21.03%	25.62%	27.52%	5.45%	12.44%	13.99%	-1.38%	-3.61%
Cash Return on Invested Capital (CROIC)	19.78%	23.72%	-6.53%	-2.53%	-1.14%	-0.96%	21.68%	21.76%	17.81%	-95.21%	-93.92%
Operating Return on Assets (OROA)	17.52%	15.74%	2.78%	16.02%	18.15%	19.43%	4.47%	10.28%	14.76%	0.47%	-1.36%
Return on Assets (ROA)	13.18%	13.59%	1.15%	11.75%	15.19%	13.47%	3.53%	7.66%	11.37%	-2.29%	-3.53%
Return on Common Equity (ROCE)	27.71%	24.77%	3.31%	21.03%	25.62%	27.52%	5.45%	12.44%	13.99%	-1.38%	-3.61%
Return on Equity Simple (ROE_SIMPLE)	18.79%	0.00%	16.61%	15.02%	15.17%	0.00%	15.65%	14.26%	12.52%	0.00%	1.23%
Net Operating Profit after Tax (NOPAT)	34	29	3.56	23	33	39	6.02	16	19	1.98	-4.88
NOPAT Margin	10.50%	9.29%	1.36%	8.53%	11.07%	13.37%	2.52%	6.05%	6.62%	0.40%	-1.22%
Net Nonoperating Expense Percent (NNEP)	45.01%	-67.64%	2.11%	2.81%	6.90%	-171.96%	-0.35%	1.66%	376.82%	4.74%	2.80%
Return On Investment Capital (ROIC_SIMPLE)	-	5.77%	-	-	-	6.43%	0.97%	-	-	0.11%	-0.28%
Cost of Revenue to Revenue	77.60%	78.06%	80.24%	75.45%	73.78%	72.92%	78.49%	75.12%	74.71%	76.22%	76.92%
SG&A Expenses to Revenue	8.89%	9.54%	14.03%	10.01%	10.18%	9.92%	13.53%	13.04%	13.02%	17.66%	16.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.90%	12.65%	18.08%	13.83%	13.72%	13.71%	18.20%	17.13%	16.93%	23.21%	24.82%
Earnings before Interest and Taxes (EBIT)	34	29	4.62	29	38	39	7.92	21	33	2.83	-5.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	44	38	15	40	48	51	19	32	44	30	19
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.78	1.54	1.77	1.27	1.74	1.60	1.84	1.94	1.86	1.35	1.02
Price to Tangible Book Value (P/TBV)	3.34	2.73	4.06	2.77	3.52	3.03	3.42	3.50	3.24	0.00	0.00
Price to Revenue (P/Rev)	0.66	0.59	0.69	0.54	0.80	0.77	0.92	1.00	1.02	1.07	0.69
Price to Earnings (P/E)	9.46	8.09	10.67	8.46	11.50	10.59	11.73	13.59	14.87	41.42	83.23
Dividend Yield	1.33%	1.48%	1.26%	1.70%	1.15%	1.21%	1.04%	0.97%	0.96%	1.10%	1.52%
Earnings Yield	10.57%	12.36%	9.37%	11.81%	8.69%	9.44%	8.52%	7.36%	6.72%	2.41%	1.20%
Enterprise Value to Invested Capital (EV/IC)	1.77	1.57	1.63	1.23	1.70	1.59	1.81	1.94	1.92	1.21	1.01
Enterprise Value to Revenue (EV/Rev)	0.67	0.57	0.78	0.61	0.83	0.78	0.94	0.99	0.99	1.59	1.17
Enterprise Value to EBITDA (EV/EBITDA)	5.36	4.53	6.71	5.25	6.77	5.97	6.59	7.33	7.86	16.50	14.83
Enterprise Value to EBIT (EV/EBIT)	7.34	6.15	9.39	7.44	9.56	8.41	9.09	10.37	11.65	32.38	42.27
Enterprise Value to NOPAT (EV/NOPAT)	7.34	6.20	11.70	7.44	9.56	7.99	9.09	10.37	11.65	37.01	42.27
Enterprise Value to Operating Cash Flow (EV/OCF)	9.95	7.05	7.77	5.19	6.33	6.01	7.03	7.52	8.34	22.85	23.30
Enterprise Value to Free Cash Flow (EV/FCFF)	9.15	6.67	0.00	0.00	0.00	0.00	8.25	8.77	10.72	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.07	0.32	0.27	0.21	0.13	0.12	0.10	0.09	0.75	0.77
Long-Term Debt to Equity	0.12	0.06	0.32	0.27	0.20	0.12	0.11	0.09	0.09	0.73	0.75
Financial Leverage	0.04	-0.01	0.17	0.14	0.04	-0.01	0.13	0.08	0.00	0.43	0.47
Leverage Ratio	1.71	1.63	1.72	1.68	1.63	1.54	1.59	1.57	1.54	2.02	1.99
Compound Leverage Factor	1.67	1.60	0.88	1.55	1.54	1.24	1.38	1.50	1.49	-12.55	6.89
Debt to Total Capital	11.16%	6.19%	24.42%	21.41%	17.23%	11.20%	10.35%	8.73%	8.35%	43.01%	43.59%
Short-Term Debt to Total Capital	0.21%	0.21%	0.32%	0.34%	0.36%	0.39%	0.40%	0.42%	0.42%	1.45%	1.50%
Long-Term Debt to Total Capital	10.95%	5.98%	24.10%	21.08%	16.87%	10.81%	9.95%	8.31%	7.93%	41.56%	42.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.84%	93.81%	75.58%	78.59%	82.77%	88.80%	89.65%	91.27%	91.65%	56.99%	56.41%
Debt to EBITDA	0.38	0.20	1.08	0.98	0.78	0.46	0.41	0.36	0.40	6.20	6.60
Net Debt to EBITDA	0.04	-0.16	0.78	0.66	0.26	0.07	0.12	-0.01	-0.29	5.37	6.11
Long-Term Debt to EBITDA	0.37	0.19	1.07	0.97	0.76	0.45	0.39	0.35	0.38	5.99	6.37
Debt to NOPAT	0.51	0.28	1.89	1.39	1.10	0.62	0.56	0.51	0.59	13.92	18.81
Net Debt to NOPAT	0.06	-0.22	1.36	0.94	0.36	0.09	0.17	-0.02	-0.44	12.04	17.42
Long-Term Debt to NOPAT	0.51	0.27	1.86	1.37	1.07	0.60	0.54	0.49	0.56	13.45	18.16
Altman Z-Score	4.24	4.35	3.71	3.50	4.06	4.24	4.68	4.74	4.71	1.62	1.55
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.93	2.01	2.22	2.22	2.12	2.03	2.27	2.22	2.36	2.24	2.39
Quick Ratio	1.00	1.08	1.06	1.16	1.25	1.16	1.12	1.21	1.42	1.08	0.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	12	21	-112	-86	-72	-76	18	35	26	-1,113	-1,098
Operating Cash Flow to CapEx	923.02%	353.55%	41.89%	471.69%	878.79%	299.21%	40.36%	438.81%	744.59%	0.00%	-109.21%
Free Cash Flow to Firm to Interest Expense	17.13	29.32	-49.78	-38.49	-35.01	-48.54	16.51	37.32	30.18	-62.88	-77.39
Operating Cash Flow to Interest Expense	71.46	67.76	1.39	15.74	31.00	28.43	3.61	34.83	52.83	0.31	-0.88
Operating Cash Flow Less CapEx to Interest Expense	63.72	48.60	-1.93	12.40	27.47	18.93	-5.33	26.89	45.74	0.38	-1.69
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.65	1.69	1.57	1.49	1.44	1.45	1.35	1.33	1.26	0.81	0.95
Accounts Receivable Turnover	11.61	11.96	13.22	11.00	11.11	11.70	13.45	12.15	11.77	8.66	11.77
Inventory Turnover	8.11	8.93	7.76	7.43	7.21	7.80	7.06	7.65	7.95	5.21	5.63
Fixed Asset Turnover	6.86	6.80	5.83	5.65	5.42	5.25	4.47	4.44	4.34	3.91	4.46
Accounts Payable Turnover	11.48	11.57	13.73	11.84	11.25	11.20	14.05	13.18	12.00	9.78	13.36
Days Sales Outstanding (DSO)	31.45	30.53	27.61	33.19	32.85	31.21	27.14	30.04	31.02	42.13	31.00
Days Inventory Outstanding (DIO)	45.00	40.87	47.02	49.12	50.66	46.82	51.68	47.71	45.93	70.11	64.84
Days Payable Outstanding (DPO)	31.79	31.53	26.58	30.84	32.44	32.58	25.97	27.70	30.41	37.31	27.32
Cash Conversion Cycle (CCC)	44.66	39.86	48.05	51.47	51.07	45.45	52.85	50.05	46.53	74.93	68.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	457	440	586	583	562	556	575	564	554	1,671	1,668
Invested Capital Turnover	2.70	2.80	2.30	2.21	2.24	2.27	1.91	1.92	1.94	1.15	1.28
Increase / (Decrease) in Invested Capital	22	7.76	116	110	106	115	-12	-19	-7.95	1,115	1,093
Enterprise Value (EV)	806	690	954	717	954	884	1,039	1,095	1,066	2,029	1,688
Market Capitalization	800	715	843	626	918	874	1,019	1,097	1,106	1,369	992
Book Value per Share	$13.51	$14.03	$14.36	$14.82	$15.96	$16.54	$16.91	$17.10	$17.94	$21.39	$20.57
Tangible Book Value per Share	$7.18	$7.91	$6.27	$6.82	$7.92	$8.75	$9.07	$9.45	$10.31	($3.43)	($3.76)
Total Capital	507	496	629	627	635	614	619	620	648	1,774	1,723
Total Debt	57	31	154	134	110	69	64	54	54	763	751
Total Long-Term Debt	55	30	152	132	107	66	62	52	51	737	725
Net Debt	6.50	-24	111	91	36	10	20	-1.97	-40	660	696
Capital Expenditures (CapEx)	5.61	14	7.48	7.49	7.29	15	9.55	7.54	6.23	-1.28	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	99	87	106	104	81	83	100	91	82	261	289
Debt-free Net Working Capital (DFNWC)	149	142	149	147	154	141	144	148	176	364	345
Net Working Capital (NWC)	148	141	147	145	152	139	142	145	174	338	319
Net Nonoperating Expense (NNE)	8.13	3.90	1.65	1.81	1.48	12	-0.23	0.74	-6.80	16	10
Net Nonoperating Obligations (NNO)	6.50	-24	111	91	36	10	20	-1.97	-40	660	696
Total Depreciation and Amortization (D&A)	9.73	9.56	11	10	11	11	11	11	11	27	25
Debt-free, Cash-free Net Working Capital to Revenue	8.19%	7.10%	8.68%	8.89%	7.11%	7.33%	8.99%	8.31%	7.61%	20.44%	20.10%
Debt-free Net Working Capital to Revenue	12.33%	11.61%	12.22%	12.62%	13.52%	12.50%	13.00%	13.41%	16.30%	28.50%	23.96%
Net Working Capital to Revenue	12.25%	11.53%	12.05%	12.43%	13.32%	12.29%	12.78%	13.17%	16.05%	26.48%	22.16%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.79	$0.74	$0.06	$0.65	$0.97	$0.83	$0.19	$0.47	$0.77	($0.52)	($0.32)
Adjusted Weighted Average Basic Shares Outstanding	33.00M	33.05M	32.95M	32.86M	32.72M	32.82M	32.83M	32.87M	32.88M	36.42M	47.02M
Adjusted Diluted Earnings per Share	$0.78	$0.74	$0.06	$0.65	$0.96	$0.83	$0.19	$0.46	$0.77	($0.52)	($0.32)
Adjusted Weighted Average Diluted Shares Outstanding	33.17M	33.21M	33.14M	33.02M	32.92M	33.03M	33.04M	33.10M	33.11M	36.65M	47.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.26M	33.13M	33.24M	32.95M	32.99M	33.00M	33.10M	33.11M	47.25M	47.26M	47.23M
Normalized Net Operating Profit after Tax (NOPAT)	24	20	3.56	23	33	28	6.02	16	19	1.98	0.65
Normalized NOPAT Margin	7.35%	6.50%	1.36%	8.53%	11.07%	9.36%	2.52%	6.05%	6.62%	0.40%	0.16%
Pre Tax Income Margin	10.40%	9.12%	0.90%	9.89%	11.95%	10.77%	2.86%	7.40%	11.43%	-3.56%	-4.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	47.56	40.24	2.05	13.07	18.31	25.24	7.41	21.72	37.49	0.16	-0.41
NOPAT to Interest Expense	47.01	40.24	1.58	10.39	16.04	25.24	5.64	16.96	21.13	0.11	-0.34
EBIT Less CapEx to Interest Expense	39.82	21.07	-1.27	9.74	14.78	15.74	-1.53	13.79	30.39	0.23	-1.21
NOPAT Less CapEx to Interest Expense	39.27	21.07	-1.74	7.05	12.51	15.74	-3.31	9.03	14.03	0.18	-1.15
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	12.63%	12.00%	13.51%	14.41%	13.33%	12.90%	12.23%	13.15%	14.30%	36.21%	110.18%
Augmented Payout Ratio	26.87%	19.47%	21.86%	28.76%	20.34%	19.67%	18.67%	13.15%	14.30%	36.21%	141.19%

Frequently Asked Questions About Quanex Building Products' Financials

When does Quanex Building Products's fiscal year end?

According to the most recent income statement we have on file, Quanex Building Products' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Quanex Building Products' net income changed over the last 10 years?

Quanex Building Products' net income appears to be on an upward trend, with a most recent value of $33.06 million in 2024, rising from $29.23 million in 2014. The previous period was $82.50 million in 2023.

What is Quanex Building Products's operating income?

Quanex Building Products's total operating income in 2024 was $54.83 million, based on the following breakdown:

Total Gross Profit: $305.62 million
Total Operating Expenses: $250.80 million

How has Quanex Building Products revenue changed over the last 10 years?

Over the last 10 years, Quanex Building Products' total revenue changed from $595.38 million in 2014 to $1.28 billion in 2024, a change of 114.6%.

How much debt does Quanex Building Products have?

Quanex Building Products' total liabilities were at $1.31 billion at the end of 2024, a 358.4% increase from 2023, and a 1,260.8% increase since 2014.

How much cash does Quanex Building Products have?

In the past 10 years, Quanex Building Products' cash and equivalents has ranged from $17.46 million in 2017 to $120.38 million in 2014, and is currently $97.74 million as of their latest financial filing in 2024.

How has Quanex Building Products' book value per share changed over the last 10 years?

Over the last 10 years, Quanex Building Products' book value per share changed from 11.21 in 2014 to 21.39 in 2024, a change of 90.7%.

Related Companies

This page (NYSE:NX) was last updated on 4/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quanex Building Products (NX) Financials

Frequently Asked Questions About Quanex Building Products' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quanex Building Products (NX) Financials

Annual Income Statements for Quanex Building Products

Quarterly Income Statements for Quanex Building Products

Annual Cash Flow Statements for Quanex Building Products

Quarterly Cash Flow Statements for Quanex Building Products

Annual Balance Sheets for Quanex Building Products

Quarterly Balance Sheets for Quanex Building Products

Annual Metrics and Ratios for Quanex Building Products

Quarterly Metrics and Ratios for Quanex Building Products

Frequently Asked Questions About Quanex Building Products' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools